Evidence map›Paper›PMID 36820310›Full record

ArticleACS bio & med chem Au2023

Improved Yield for the Enzymatic Synthesis of Radiolabeled Nicotinamide Adenine Dinucleotide.

Jared Eller, Shivansh Goyal, Xiaolu A Cambronne

Abstract read
In one paragraph

Article in ACS bio & med chem Au, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Mitochondrial NADScience advances · 2025
    Article
  2. The role of nicotinamide adenine dinucleotide salvage enzymes in cardioprotection.Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2024
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jared EllerDepartment of Molecular Biosciences and LiveSTRONG Cancer Institute, University of Texas at Austin, Austin, Texas 78712, United States.
Shivansh GoyalDepartment of Molecular Biosciences and LiveSTRONG Cancer Institute, University of Texas at Austin, Austin, Texas 78712, United States.ORCID https://orcid.org/0000-0003-3735-2475
Xiaolu A CambronneDepartment of Molecular Biosciences and LiveSTRONG Cancer Institute, University of Texas at Austin, Austin, Texas 78712, United States.ORCID https://orcid.org/0000-0002-3547-448X

Funding

Gatekeepers of Mitochondrial NAD+DP2GM126897 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI CAMBRONNE, XIAOLU ANG · 2017 to 2021
$2.4M
NIGMS NIH HHS DP2 GM126897
6 · The paper itself

Abstract

Labeled β-nicotinamide adenine dinucleotide (NAD) analogues have been critical for uncovering new biochemical connections and quantitating enzymatic activity. They function as tracers for enzymology, flux analyses, and in situ measurements. Nevertheless, there is limited availability of specific types of analogues, especially radiolabeled NAD isotopologues. Here, we describe an improved enzymatic synthesis reaction for

Identifiers

PMID36820310
PMCPMC9936495

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.